INVO Fertility (IVF) Income towards Parent Company (2011 - 2026)
INVO Fertility's (IVF) quarterly Income towards Parent Company came in at -$1.7 million in Q1 2026, up 89.02% year-on-year from -$924697.4 in Q1 2025, and down 422.92% on a QoQ basis from $541247.0 in Q4 2025.
INVO Fertility (IVF) Income towards Parent Company (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has 16 years of Income towards Parent Company data on file, last reported at -$1.7 million in Q1 2026.
- On a quarterly basis, Income towards Parent Company rose 89.02% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$16.7 million, a 29.17% increase from a year earlier, with the FY2025 full-year figure at -$15.9 million, down 72.67% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$1.7 million, down from $541247.0 in the prior quarter.
- Over the last five years, Income towards Parent Company for IVF reached as high as $541247.0 in Q4 2025 and fell as low as -$15.9 million in Q1 2025.
- Historically, Income towards Parent Company has averaged -$3.6 million across 5 years, with a median of -$2.2 million in 2024.
- Across the five-year window, Income towards Parent Company slumped 2818.28% in 2022 and jumped 114.46% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$2.8 million in 2022, then advanced by 28.98% to -$2.0 million in 2023, then slumped by 90.44% to -$3.7 million in 2024, then soared by 114.46% to $541247.0 in 2025, then slumped by 422.92% to -$1.7 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$1.7 million in Q1 2026, $541247.0 in Q4 2025, and -$14.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | INVO Fertility | 1.50 Mn | -3.40 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.75 Mn |
| Dec 31, 2025 | 541,247.00 |
| Sep 30, 2025 | -14.92 Mn |
| Jun 30, 2025 | -541,247.00 |
| Mar 31, 2025 | -15.91 Mn |
| Dec 31, 2024 | -3.74 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | -1.97 Mn |
| Sep 30, 2023 | -1.25 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -2.80 Mn |
| Mar 31, 2022 | -2.95 Mn |
| Dec 31, 2021 | 101,782.00 |
| Sep 30, 2021 | -2.48 Mn |
| Jun 30, 2021 | -1.82 Mn |